Can a VR headset calm chemo anxiety? new study tests hypnosis in prostate cancer patients
NCT ID NCT04533958
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using virtual reality hypnosis before chemotherapy infusions could lower anxiety in men with metastatic prostate cancer. Fifty-three patients were randomly assigned to either receive the VR hypnosis session or standard care before each docetaxel infusion. Researchers measured anxiety levels and nausea to see if the VR approach made treatment less stressful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HYPNO VR® device (virtual reality hypnosis software with headset and headphones)
- What this could lead to
- If it works, this could offer a drug-free way to reduce anxiety and nausea during chemotherapy for men with metastatic prostate cancer.
- What could go wrong
- This is a small, single-center study with only 53 participants, so results may not apply to everyone. The effect on anxiety may be modest or no different from standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHP Saint-Grégoire
Saint-Grégoire, 35760, France
-
Clinique Pasteur-Lanroze
Brest, 29200, France
-
Clinique de la Côte d'Emeraude
St-Malo, 35400, France
-
Hospital Lusiadas Amadora
Amadora, 2724-002, Portugal
-
Hospital Lusiadas Lisboa
Lisbon, 1500-458, Portugal
-
Hospital Lusiadas Porto
Porto, 4050-115, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blast of testosterone shrink hard-to-treat prostate cancer?
- A PET scan and a blood test may predict which men with advanced prostate cancer will benefit from targeted therapy
- New drug ORIC-944 targets Hard-to-Treat prostate cancer
- Precision radiotherapy may buy time for men with spreading prostate cancer
- Mapping Cancer's next move: study tracks where prostate cancer returns after aggressive radiotherapy
- Smart scans may slash radiation doses for metastatic prostate cancer